Skip to main content
. 2010 Sep 14;43(10):521–528. doi: 10.1152/physiolgenomics.00158.2010

Table 1.

Temporal changes in the microRNA transcriptome following ischemic stroke

miRNA Early Phase ≤24 h Late Phase 24–72 h Authors
Upregulated at one or both phases 17 up (J) up (D) D, J
134 up up D, J
140 up up D, J
145 up up D, J
206 up up D, J
214 up up D, J
290 up up D, J
320 up up D, J
330 up up D, J
331 up up D, J
292-5p up (J) up (D) D, J
324-3p up up D, J
324-5p up up D, J
422b up (J) up (D) D, J
223 NC up D, J, L
Mixed at both phases 7a down (J) down (D), up (J) D, J
20a down (J) up (D) D, J
25 down (J) up (D) D, J
138 up (J) down (D) D, J
151 down (J) up (D) D, J
361 down (J) up (D) D, J
Downregulated at one or both phases 26b down down D, J
27a down (J) down (D, J) D, J
29b down down D, J
29c down down D, J
30e down down D, J
98 down down D, J
137 down (J) down (D, J) D, J
218 down (J) down (D, J) D, J
335 down (J) down (D, J) D, J
664 down (D, J) down (D) D, J
379 NC down D, J
539 NC down D, J

Table collates microRNA common to at least 2 of 3 preclinical studies to perform transcriptome-wide analysis following focal cerebral ischemia in rat. Final column designates studies in agreement: D(12), J(28), L(39). NC, no change. Note: specific conditions of experimental MCAO differ across studies and likely contribute to variability in transcriptome changes. For example, D and J employed transient ischemia while L employed permanent ischemia. Refer to original manuscripts for detailed descriptions of experimental stroke procedures.